Pam Murphy | IR |
Bill Collier | President and CEO |
Gaston Picchio | Chief Development Officer |
Mike Sofia | Chief Scientific Officer |
Dave Hastings | CFO |
Ed Arce | H.C. Wainwright |
Brian Skorney | Robert W. Baird |
Mayank Mamtani | B. Riley |
Kelechi Chikere | Jefferies |
Roy Buchanan | JMP Securities |
Keay Nakae | Chardan |
Ladies and gentlemen, thank you for standing by, and welcome to Arbutus Biopharma Corporation Four Quarter and Year End 2020 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Pam Murphy.